PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

Yang, JB; Xing, PF; Kong, YH; Xu, ML; Zhang, LY

Zhang, LY (通讯作者),Soochow Univ, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Peoples R China.;Zhang, LY (通讯作者),Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China.;Zhang, LY (通讯作者),Soochow Univ, Lab Combined Radiotherapy & Immunotherapy Canc, Affiliated Hosp 2, Suzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Patients with chemo-refractory metastatic colorectal cancer (mCRC) have poor prognoses. The application of programmed cell death protein 1 (PD-1)/prog......

Full Text Link